Recordati buys Sanofi’s drug for autoimmune disease for $825 million
Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's.
Drugs
Health
Pharma
Drugs
Health
Pharma
Kezar Life Sciences halts mid-stage lupus nephritis trial after four people die
Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.
Drugs
Health
Medical
New study identifies possible cause of Lupus, may help in developing cure
HQ Team July 16, 2024: A new study by Northwestern Medicine and Brigham and Women’s Hospital researchers has identified a possible cause for.
Drugs
Medical
Pharma
Argenx’s Vyvgart faces setback in autoimmune treatment trial
HQ Team November 28, 2023: Argenx SE, a Belgian biopharmaceutical announced that its experimental drug Vyvgart Hytrulo failed in trials in treating immune.
Climate
Health
Pharma
Environment, lifestyle behind epidemic of autoimmune diseases
HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein.
Drugs
Health
Medical
Researchers develop ‘inverse’ vaccine for autoimmune diseases
HQ Team Sept 14, 2023: Researchers at the University of Chicago’s Pritzker School of Molecular Engineering have developed an “inverse vaccine” to combat.
Drugs
Pharma
Moderna in $35 million licensing deal with CytomX
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
Drugs
Medical
Pharma
Scientists use nanoparticle therapy to cure arthritis in mice
A nanoparticle treatment has "cured" mice that had a genetic arthritis condition, according to Scripps Research, a nonprofit US medical research institution.